title: Interindividual variation in olanzapine concentration influenced by UGT1A4 L48V polymorphism in serum and upstream FMO polymorphisms in cerebrospinal fluid.
authors.forename: Mao
authors.initials: M
authors.lastname: Mao
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Skogh
authors.forename: Maria Gabriella
authors.initials: MG
authors.lastname: Scordo
authors.forename: Marja-Liisa
authors.initials: ML
authors.lastname: Dahl
mesh_terms: D014150:Antipsychotic Agents / Q000097:blood*; D001569:Benzodiazepines / Q000097:blood* / Q000134:cerebrospinal fluid*; D019388:Cytochrome P-450 CYP1A2 / Q000378:metabolism*; D019389:Cytochrome P-450 CYP2D6 / Q000378:metabolism*; D005260:Female; D006801:Humans; D008297:Male; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000097:blood*; D011618:Psychotic Disorders / Q000097:blood* / Q000134:cerebrospinal fluid*; D012559:Schizophrenia / Q000097:blood* / Q000134:cerebrospinal fluid* / Q000188:drug therapy*; D012907:Smoking; D015430:Weight Gain / Q000502:physiology*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D019388:Cytochrome P-450 CYP1A2; D019389:Cytochrome P-450 CYP2D6